AnteoTech’s COVID-19 (SARS- CoV2) Antigen Rapid Test is a disposable immunochromatographic test for the detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from the respiratory mucosa or saliva sample. The test provides for the diagnosis of COVID-19 in the early stages of infection allowing for rapid diagnosis and decision support in the treatment and spread prevention of COVID-19.
The in-vitro diagnostic (IVD) is classified a Class III device in accordance with therapeutics goods administration. Product not available for sale or for diagnostic use. Pending regulatory approval.